Daylight (DaylightRx)
Big Health
First FDA-cleared digital therapeutic for GAD with 71% improvement rate.
About Daylight (DaylightRx)
DaylightRx (formerly Daylight) is the first FDA-cleared digital treatment for generalized anxiety disorder (GAD), receiving clearance in September 2024. Developed by Big Health, DaylightRx delivers Cognitive Behavioral Therapy (CBT) techniques through an engaging digital program for adults 22+. Clinical trials demonstrate 71% patient improvement rates in anxiety symptoms. Medicare coverage began January 1, 2025 through new CMS Digital Mental Health Treatment (DMHT) G-codes. DaylightRx is distributed through employer wellness programs via PBM integration, with partners including Evernorth and CVS Caremark Point Solutions Management.
Best For
- • Health systems prescribing evidence-based anxiety treatment
- • Employers seeking clinically validated digital mental health
- • Psychiatrists offering non-pharmacological GAD options
- • Primary care practices treating anxiety disorders
Not Ideal For
- • Solo practitioners (enterprise/B2B model)
- • Patients under 22 years old
- • Acute anxiety or panic disorder treatment
- • Those seeking OTC/consumer anxiety apps
Pricing
Utilization-based (no PEPM fees)
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.
Sleepio (SleepioRx)
FDA-cleared CBT-I digital therapeutic for chronic insomnia with 76% improvement rate.
Koa Health
Clinical-first digital CBT platform with 7 DTx products backed by 21 clinical trials.
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.